Staged-surgery with permanent pathology for the management of high-risk nonmelanoma skin cancer of the nose
| dc.contributor.author | Eskiizmir G. | |
| dc.contributor.author | Gençoǧlan G. | |
| dc.contributor.author | Temiz P. | |
| dc.contributor.author | Hirçin Z. | |
| dc.contributor.author | Ermertcan A. | |
| dc.date.accessioned | 2025-04-10T11:15:27Z | |
| dc.date.available | 2025-04-10T11:15:27Z | |
| dc.date.issued | 2011 | |
| dc.description.abstract | The objective of the study was to investigate the effect of staged-surgery with permanent pathology on tumour recurrence of high-risk nonmelanoma skin cancers (NMSCs) of the nose and to determine the factors associated with subclinical spread and deep-margin involvement. Twenty-one patients who underwent staged-surgery with permanent pathology for high-risk NMSCs of the nose between 2007 and 2008 were prospectively followed-up for tumour recurrence. The incidence of tumour recurrence after staged-surgery with permanent pathology was 0%. A positive correlation between perineural involvement and subclinical spread (p = .012); and a statistically significant relationship between infiltrative type basal cell carcinoma (BCC) and deep-margin involvement (p = .033) was detected. Staged-surgery with permanent pathology is a reliable surgical method for complete excision of high-risk NMSCs of the nose and provides a significant decrease in tumour recurrence. Perineural involvement may cause subclinical spread, and infiltrative type BCC may invade deeper structures of the nose. © 2010 Springer-Verlag. | |
| dc.identifier.DOI-ID | 10.1007/s00405-010-1324-x | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/51007 | |
| dc.title | Staged-surgery with permanent pathology for the management of high-risk nonmelanoma skin cancer of the nose | |
| dc.type | Article |